• In the present study, we characterized the genetic determinants associated with the resistance to cef tazidime/avibactam (CAZ-AVI), meropenem/vaborbactam (MER-VAB), imipenem/relebactam (IMI-REL) and cefiderocol (CFD) in a carbapenemase-producing Klebsiella pneumoniae strain isolated from a critically ill patient. (unibo.it)
  • Other β-lactam antibiotics included in the study were ceftazidime sodium, cefepime hydrochloride, meropenem, and imipenem/cilastin sodium. (medpagetoday.com)
  • Comparison of 30-min and 3-h infusion regimens for imipenem/cilastatin and for meropenem evaluated by Monte Carlo simulation. (druglib.com)
  • The efficacy and safety of meropenem and tobramycin vs ceftazidime and tobramycin in the treatment of acute pulmonary exacerbations in patients with cystic fibrosis. (druglib.com)
  • Meropenem versus imipenem-cilastatin for the treatment of hospitalized patients with complicated skin and skin structure infections: results of a multicenter, randomized, double-blind comparative study. (druglib.com)
  • Pharmacokinetic evaluation of meropenem and imipenem in critically ill patients with sepsis. (druglib.com)
  • Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empirical therapy for neutropenic fever in children with malignancy. (druglib.com)
  • Prophylaxis with meropenem of septic complications in acute pancreatitis: a randomized, controlled trial versus imipenem. (druglib.com)
  • A randomized, controlled clinical trial on meropenem versus imipenem/cilastatin for the treatment of bacterial infections. (druglib.com)
  • Cost-effectiveness of cefepime + netilmicin or ceftazidime + amikacin or meropenem monotherapy in febrile neutropenic children with malignancy in Turkey. (druglib.com)
  • Meropenem versus ceftazidime as empirical monotherapy in febrile neutropenia of paediatric patients with cancer. (druglib.com)
  • Meropenem versus ceftazidime in the treatment of cancer patients with febrile neutropenia: a randomized, double-blind trial. (druglib.com)
  • Meropenem versus imipenem/cilastatin as empirical monotherapy for serious bacterial infections in the intensive care unit. (druglib.com)
  • Meropenem versus imipenem/cilastatin in the treatment of sepsis in Chinese patients. (druglib.com)
  • Meropenem versus ceftazidime as empirical monotherapy for febrile neutropenic cancer patients. (druglib.com)
  • Cost-effectiveness study of imipenem/cilastatin versus meropenem in intra-abdominal infections. (druglib.com)
  • Comparison of meropenem with amikacin plus ceftazidime in the empirical treatment of febrile neutropenia: a prospective randomised multicentre trial in patients without previous prophylactic antibiotics. (druglib.com)
  • This difference may explain why meropenem is less neurotoxic than imipenem, which has a more basic side chain. (facmedicine.com)
  • For example, ceftazidime and meropenem are less neurotoxic than cefepime and imipenem. (facmedicine.com)
  • Melioidosis treatment is often prolonged, associated with an intensive phase (2-6 weeks) of injectable antibiotic (intravenous ceftazidime, meropenem or imipenem) followed by oral eradication therapy (trimethoprim-sulfamethoxazole +/- doxycyline +/- amoxicillin-clavulanic acid) for 3-6 months. (cgh.com.sg)
  • Antimicrobial susceptibility profile showed that the majority of the isolates were sensitive to Imipenem and Nitrofurantoin while most were significantly resistant to, augmentin, ampicillin, cotrimoxazole, gentamicin, cefuroxime, cefotaxime, and ceftazidime. (ispub.com)
  • Individual discs containing 30 μg of ceftazidime, ceftriaxone and cefotaxime were placed on the plate at a distance of 15 mm (edge to edge) from an amoxicillin/clavulanic acid disc (20-10 μg) placed at the center of the plate. (scialert.net)
  • The combination of ceftazidime and avibactam injection is used with metronidazole (Flagyl) to treat abdominal (stomach area) infections. (medlineplus.gov)
  • The combination of ceftazidime and avibactam injection comes as a powder to be added to fluid and injected intravenously (into a vein). (medlineplus.gov)
  • Your doctor will tell you how long to use ceftazidime and avibactam injection. (medlineplus.gov)
  • You may receive ceftazidime and avibactam injection in a hospital or you may administer the medication at home. (medlineplus.gov)
  • If you will be receiving ceftazidime and avibactam injection at home, your healthcare provider will show you how to use the medication. (medlineplus.gov)
  • You should begin to feel better during the first few days of treatment with ceftazidime and avibactam injection. (medlineplus.gov)
  • If you still have symptoms of infection after you finish ceftazidime and avibactam injection, tell your doctor. (medlineplus.gov)
  • any other medications, or any of the ingredients in ceftazidime and avibactam injection. (medlineplus.gov)
  • If you become pregnant while using ceftazidime and avibactam injection, call your doctor. (medlineplus.gov)
  • Ceftazidime and avibactam injection may cause side effects. (medlineplus.gov)
  • Ceftazidime/avibactam (CAZ-AVI) is a fixed-dose antibiotic approved in Europe and the United States for treating (in combination with metronidazole) cIAI in adult hospitalised patients who have limited or no alternative treatment options. (biomedcentral.com)
  • Hashem Hospital, Jordan between August daily and group D received imipenem. (who.int)
  • Streptococcus species [ 3 ], although an in- tion as determined by the Wagner classifi- creasing number of patients have been en- cation. (who.int)